bedard-thumb-250x175-700

Mariners decline 2011 options on Erik Bedard, Jose Lopez, and Russell Branyan

3 Comments

Seattle declined a trio of 2011 options today: Erik Bedard for $8 million, Russell Branyan for $5 million, and Jose Lopez for $4.5 million.

Bedard and Branyan are now free agents, while the Mariners still control Lopez as an arbitration-eligible player. However, there’s a strong chance they’ll non-tender him by the December 2 deadline unless they can find another team interested in dealing for him before then.

There’s also a small chance they could decide to keep Lopez while hoping he receives a modest raise on his 2010 salary of $2.3 million coming off a career-worst season, perhaps giving him a chance to recoup some value before looking to deal him at midseason (or sooner, if 2009 first-round pick Dustin Ackley is ready to take over second base).

Bedard missed the entire season following shoulder surgery, so declining his option was a no-brainer, but choosing not to bring Branyan back for $5 million is somewhat surprising considering the Mariners traded a pair of prospects to the Indians for him in June. Neither player was a top prospect and picking up a half-year rental is obviously commonplace throughout baseball, but 101-loss teams usually aren’t doing the renting.

Jake Diekman will miss at least half of the 2017 season

TORONTO, ON - OCTOBER 9: Jake Diekman #41 of the Texas Rangers works against the Toronto Blue Jays in the sixth inning during game three of the American League Division Series at Rogers Centre on October 9, 2016 in Toronto, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
Leave a comment

Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.

Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.

The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.

The Blue Jays and Bautista have reached a one year deal

TORONTO, ON - OCTOBER 19:  Jose Bautista #19 of the Toronto Blue Jays looks on during batting practice prior to game five of the American League Championship Series against the Cleveland Indians at Rogers Centre on October 19, 2016 in Toronto, Canada.  (Photo by Vaughn Ridley/Getty Images)
Getty Images
2 Comments

It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.

The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.